Friday, January 13, 2017

BRIEF-KALYTERA THERAPEUTICS ENTERS INTO BINDING LETTER OF INTENT TO ACQUIRE TALENT BIOTECHS

* KALYTERA THERAPEUTICS ENTERS INTO BINDING LETTER OF INTENT

TO ACQUIRE TALENT BIOTECHS AND ITS PHASE 2 CLINICAL-STAGE GRAFT

VERSUS HOST DISEASE PROGRAM

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)